Roder D - Search Results

1

Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer.

Tiruye T, Roder D, FitzGerald LM, O'Callaghan M, Moretti K, Beckmann K. Tiruye T, et al. Among authors: roder d. Cancer Epidemiol. 2023 Oct 28;87:102482. doi: 10.1016/j.canep.2023.102482. Online ahead of print. Cancer Epidemiol. 2023. PMID: 39492113 Free article.

2

Variations in colorectal cancer pattern of care by age and comorbidity in South Australia.

Gheybi K, Buckley E, Vitry A, Roder D. Gheybi K, et al. Among authors: roder d. Cancer Med. 2023 Jun;12(11):12118-12127. doi: 10.1002/cam4.5901. Epub 2023 Apr 21. Cancer Med. 2023. PMID: 37084009 Free PMC article.

3

Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists.

Dars S, Buckley E, Beckmann K, Roder D, Banwell H. Dars S, et al. Among authors: roder d. J Foot Ankle Res. 2023 Jun 9;16(1):33. doi: 10.1186/s13047-023-00632-0. J Foot Ankle Res. 2023. PMID: 37291602 Free PMC article.

4

Risk of secondary malignancy following radiation therapy for prostate cancer.

Tiruye T, David R, O'Callaghan M, FitzGerald LM, Higgs B, Kahokehr AA, Roder D, Beckmann K. Tiruye T, et al. Among authors: roder d. Sci Rep. 2023 Nov 16;13(1):20083. doi: 10.1038/s41598-023-45856-z. Sci Rep. 2023. PMID: 37973983 Free PMC article.

5

Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.

Tiruye T, Roder D, FitzGerald LM, O'Callaghan M, Moretti K, Beckmann K. Tiruye T, et al. Among authors: roder d. Cancer Epidemiol. 2024 Feb;88:102516. doi: 10.1016/j.canep.2023.102516. Epub 2023 Dec 22. Cancer Epidemiol. 2024. PMID: 38141473 Free article.

6

Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection.

Tiruye T, O'Callaghan M, FitzGerald LM, Moretti K, Jay A, Higgs B, Kichenadasse G, Caughey G, Roder D, Beckmann K. Tiruye T, et al. Among authors: roder d. Clin Genitourin Cancer. 2024 Apr;22(2):599-609.e2. doi: 10.1016/j.clgc.2024.01.018. Epub 2024 Feb 1. Clin Genitourin Cancer. 2024. PMID: 38369388 Free article.

7

Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study.

Tiruye T, Roder D, FitzGerald LM, O'Callaghan M, Moretti K, Caughey GE, Beckmann K. Tiruye T, et al. Among authors: roder d. Prostate. 2024 Sep;84(12):1138-1145. doi: 10.1002/pros.24750. Epub 2024 May 26. Prostate. 2024. PMID: 38798040

8

Innovative use of Australian cancer registry data for early detection of the effects of epidemics and other mass disruptions on cancer incidence.

Ahmed M, Walton R, Creighton N, Gugusheff J, Saini N, Moritz P, Roder D. Ahmed M, et al. Among authors: roder d. Cancer Epidemiol. 2024 Aug;91:102608. doi: 10.1016/j.canep.2024.102608. Epub 2024 Jul 5. Cancer Epidemiol. 2024. PMID: 38970918 Free article.

9

Comparing post-treatment urinary and colorectal procedures in prostate cancer patients using population-based linked data.

Tiruye T, Jay A, Higgs B, O'Callaghan M, FitzGerald LM, Moretti K, Roder D, Beckmann K. Tiruye T, et al. Among authors: roder d. Int Urol Nephrol. 2024 Dec 10. doi: 10.1007/s11255-024-04304-1. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39658770

10

Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer.

Gheybi K, Buckley E, Vitry A, Roder D. Gheybi K, et al. Among authors: roder d. Front Public Health. 2023 Apr 6;11:1101771. doi: 10.3389/fpubh.2023.1101771. eCollection 2023. Front Public Health. 2023. PMID: 37089488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters